In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow ...

HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...

Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...

Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Noel Anderson, CSO at American Red Cross, Sirsij Peshin, CPO at Pfizer & Lauren Riley, CSO at United Airlines, on how ...

Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...

Zoetis has seen its valuation compress dramatically, now trading at just 12x trailing earnings after a 52% 12-month share ...

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine ...

A Lanarkshire woman who has been left with a brain tumour the "size of a tangerine" after taking a contraceptive jag has told how doctors first described it as a 'Wonderdrug'. Kirsty McCord has joined ...

Pfizer's (NYSE: PFE) shares have significantly underperformed broader equities over the past three years. The company's ...